_cannabis-stocks-soar-as-biden-to-reclassify-marijuana-as-schedule-iii.jpg "Cannabis Stocks Soar as Biden to Reclassify Marijuana as Schedule III from samsung a20 india price Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 0:40
👁 View: 265K times
✓ Published: 02-May-2024
👁 View: 265K times
✓ Published: 02-May-2024
Description:
The Biden administration plans to reclassify marijuana as a Schedule III substance, placing it with drugs like Tylenol with codeine according to four sources. For over 50 years, marijuana has been a Schedule I substance, in the same category as heroin and methamphetamines. Cannabis stocks surged on the otherwise down day for markets, with ETFs like MSOS and MJUS jumping around 19-20%. Curaleaf Holdings and Trulieve Cannabis saw share price increases of 19-30% touching new 52-week highs. Schedule III classification would define marijuana as having a moderate to low potential for dependence.
The Biden administration plans to reclassify marijuana as a Schedule III substance, placing it with drugs like Tylenol with codeine according to four sources. For over 50 years, marijuana has been a Schedule I substance, in the same category as heroin and methamphetamines. Cannabis stocks surged on the otherwise down day for markets, with ETFs like MSOS and MJUS jumping around 19-20%. Curaleaf Holdings and Trulieve Cannabis saw share price increases of 19-30% touching new 52-week highs. Schedule III classification would define marijuana as having a moderate to low potential for dependence.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_no-dynamic-pricing-at-wetherspoon-says-tim-martin.webp "The pub chain’s boss has ruled out the adoption of dynamic pricing, a kind of Uber-style surge pricing for pints, which big-name rivals are reportedly adopting.")
_trump-media-amp-technology-group39s-stock-surges-9-amid-ceo39s-call-for-investigation.webp "Trump Media & Technology Group's stock price jumped over 9% after the company's CEO, Devin Nunes, asked House GOP leaders to investigate possible \")
_samsung-the-frame-2024-tv.webp "Tom's Guide goes hands-on with Samsung The Frame 2024, the newest edition of the company’s internet-famous lifestyle TV that looks like museum art when it’s on standby.")
_ibm-stock-plummets-as-disappointing-q1-sales-growth-as-it-aims-to-boost-revenue-and-profit-margins-with-366-4-billion-ha.webp "IBM's stock price dropped 9% after hours as its first-quarter sales growth of 1% to $14.5 billion disappointed investors. IBM's consulting division, it's second-largest, reported flat revenues of $5.2 billion, reflecting a \")
_samsung-galaxy-z-fold-5-reviews.webp "The Galaxy Z Fold 5 is lighter and thinner than the Z Fold 4 and features a sleeker Flex hinge with less moving parts. But the other upgrades aren’t that impressive and Samsung takes very few risks with its flagship $1,799 foldable phone. <br/><br/>Here’s the pros and cons of the Z Fold 5 based on our hands-on impressions, including the new Snapdragon 8 Gen 2 chip, slightly better cameras and improved multitasking.")
_bullish-tuesday-for-marijuana-stocks-elixinol-wellness-item-9-labs-among-top-gainers.webp "Several marijuana stocks saw significant gains on Tuesday, with Elixinol Wellness and Item 9 Labs leading the way with increases of over 100%. Other top gainers included Canopy Growth, Aurora Cannabis, Tilray, and others, which saw their share prices rise over 30%. Cannabix Technologies, CV Sciences, Urban-Gro, SNDL, and others also had double-digit percentage increases. Stocks that saw declines included Charlottes Web Holdings, Pharmadrug, Affinor Growers, and CordovaCann, all falling over 15%.")
⏲ 0:35 👁 190K
_apple-shares-down-10-ahead-of-q2-earnings-report-as-investors-eye-iphone-sales-performance.webp "Apple is set to report second-quarter earnings on Thursday, with Wall Street watching closely for updates on iPhone sales. Shares of Apple are down over 10% year-to-date in 2024, facing challenges including weaker iPhone demand in China and increased competition. Many analysts are focused on Apple's \")
⏲ 0:36 👁 665K
_samsung-galaxy-watch-6-and-6-classic.webp "Samsung Galaxy Watch 6 and Galaxy Watch 6 Classic.<br/><br/>Refinements to the watch design and performance look to create one of the most compelling Android smartwatch experiences yet. Plus, we know many people will be thrilled about the return of the physical rotating bezel.")
_no-dynamic-pricing-at-wetherspoon-says-tim-martin.jpg)
_trump-media-amp-technology-group39s-stock-surges-9-amid-ceo39s-call-for-investigation.jpg)
_samsung-the-frame-2024-tv.jpg)
_ibm-stock-plummets-as-disappointing-q1-sales-growth-as-it-aims-to-boost-revenue-and-profit-margins-with-366-4-billion-ha.jpg)
_samsung-galaxy-z-fold-5-reviews.jpg)
_bullish-tuesday-for-marijuana-stocks-elixinol-wellness-item-9-labs-among-top-gainers.jpg)
_apple-shares-down-10-ahead-of-q2-earnings-report-as-investors-eye-iphone-sales-performance.jpg)
_samsung-galaxy-watch-6-and-6-classic.jpg)
![[+]](/images/menu.gif){kind=small}